Ascendis aiming to become market leader

Ascendis Pharma, which received FDA approval for its weekly administered growth hormone Skytrofa from the FDA on Wednesday, is striving for market leadership, says Jesper Høiland, Global Commercial Officer at the company.
Photo: Kevin Grønnemann
Photo: Kevin Grønnemann
BY ANDREAS LØNSTRUP, TRANSLATED BY CATHERINE BRETT

Ascendis Pharma has announced that it aims to become a market leader, Danish financial daily Børsen reports.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading